EGFR and brain neoplasm: Endersby et al demonstrated the erythroblastic leukemia viral oncogene homolog inhibitor (pan-ERBB inhibitor) Dacomitinib inhibited EGFR signaling in in vitro models of pineoblastoma and had efficacy in orthotopic models of pediatric brain tumors.12 Many EGFR inhibitors have been tested in children.